![Géraldine Honnet](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Géraldine Honnet is currently the Chief Medical Officer at Sensorion SA since 2020.
Prior to this, she worked as the Director-Development at Genethon from 2017 to 2020, as a Senior Clinical Manager at Transgene SA from 2007 to 2011, and as a Medical Director at PAREXEL International Corp.
from 2001 to 2005.
Postes actifs de Géraldine Honnet
| Sociétés | Poste | Début |
|---|---|---|
| SENSORION | Directeur Technique/Scientifique/R&D | 18/02/2020 |
Anciens postes connus de Géraldine Honnet
| Sociétés | Poste | Fin |
|---|---|---|
Genethon
 Genethon BiotechnologyHealth Technology Develops gene therapy products for rare diseases | Corporate Officer/Principal | 01/01/2020 |
| TRANSGENE | Corporate Officer/Principal | 01/04/2011 |
| PAREXEL INTERNATIONAL CORPORATION | Directeur Technique/Scientifique/R&D | 01/09/2005 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
25
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
PAREXEL International Corp.
 PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
Transgene SA
 Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
Sensorion SA
 Sensorion SA Pharmaceuticals: MajorHealth Technology Operates as a research and development company that discovers drugs to treat inner ear disorders | Health Technology |
Genethon
Genethon BiotechnologyHealth Technology Develops gene therapy products for rare diseases | Health Technology |
